Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05295654
Other study ID # Kinect validity study
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 14, 2022
Est. completion date December 31, 2024

Study information

Verified date October 2022
Source Vrije Universiteit Brussel
Contact Eva Swinnen, Prof. Ph.D
Phone 003224774527
Email eva.swinnen@vub.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this research is to investigate the validity of the Kinect™ sensor in post-stroke patients and in healthy test subjects during analytic and functional movements. Measurements will be compared with the Vicon-camera system (currently seen as the golden standard).


Description:

STUDY DESIGN This study is a cross-sectional study in which healthy people and people post stroke will perform 1 session where we will investigate the validity of the Kinect sensor. MATERIALS 1. The VICON system The Vicon Camera system is a marker-based system (MBS) to evaluate and analyse movements. Markers are placed on predetermined locations on the skin of the patient according to the Plug in Gait (PIG) full body model. Examination will take place in underwear. A 14-camera infrared opto-electronic video-based motion analysis system with a sample rate of 100 Hz (Vicon MX T40-S, Vicon Motion Systems, Oxford, UK) is used as golden standard. Two synchronized video cameras (Bonita 720C, Vicon, UK) will film the front and side of the participants at a sample rate of 100 Hz. 2. The Kinect system The Kinect™ system is a markerless-system. It uses a skeleton model to estimate the joint and relative segment orientations. The Kinect-camera will be placed on a tripod at 1,5m height and patients will stand 2m from the camera as recommended by the manufacturer The Kinect™ Azure is the newest version of this system and will be used in this study. PROCEDURE All participants will be informed about the study (information document) and a confirmed written informed consent will be obtained by each participant. Baseline demographic and/or clinical characteristics from participants will be obtained by questioning and by searching medical files. The participant will perform following analytical movements bilateral, both in sitting and standing position: Hip: - Hip flexion (standing position): participant lifts one leg in standing position. - Hip flexion (sitting position): participant lifts one knee as high as possible while seated. The leg can be bend. - Hip abduction (standing position): participant lifts one leg sidewards as high as possible. - Hip abduction (sitting position): participant starts with two knees together and then moves one knee outwards as far as possible. - Hip adduction: patient moves one leg to the other side (in front of the standing leg) Knee: - Knee flexion (standing position): participant bends through his/her knees as deep as possible - Knee flexion (standing position): participant brings one foot towards the butt while maintaining the thigh in the same position - Knee flexion (sitting position): participant sits on a chair and moves one foot backward (under the chair). - Knee extension (sitting position): participant sits on a chair and extend his/her knee. Shoulder: - Shoulder anteflexion: participant moves the arm upward in front of him/her as high as possible. - Shoulder abduction (standing position): participant moves the arm upward next to his/her body as high as possible. - Shoulder adduction: participant moves his/her arm in front of the body to the other side - Shoulder horizontal adduction: participant lifts his/her arm to an angle of 90° and then moves the arm to the other shoulder (like going to touch the other shoulder with the hand that moves), but the elbow stays extended. Elbow: - Elbow flexion in 90° abduction in frontal plane: participant holds the arm in an angle of 90° next to his/her body and moves the hand towards the shoulder while keeping the upper arm in the same position. - Elbow flexion in 90° anteflexion in sagittal plane: participant holds the arm in an angle of 90° in front of his/her body and moves the hand towards the shoulder while keeping the upper arm in the same position. - Elbow flexion in 0° abduction: participant needs to bring the hand towards the shoulder in the front of his/her body while keeping the upper arm against the trunk The following functional movements will be performed: - Grasping + hand-to-mouth movement: The participant starts with hands next to his/her body. The participant will have to grasp something and bring it to his/her mouth. - Sit-to-stand: The participant is seated and will have to stand up straight. Afterwards, the participant has to sit down again. - Touching shoulder with heterolateral hand: The arm of the participant will hang next to his/her body. The participant has to touch the heterolateral shoulder. This will be performed with both sides. Participants will perform 5 repetitions per movement, with 2 seconds between every repetition. Each side is moved separately. If necessary, for safety reasons, the participant can use a walking aid to maintain the balance (e.g. rollator, crutch, …). STATISTICAL ANALYSIS Statistical analysis will be performed using SPSS version 23 (IBM, Chicago, IL). Significance will be set at 5%. The statistical analysis will be performed by the investigators. To determine the validity, intraclass correlation coefficients will be calculated. Based on the 95% confidence intervals of the ICC estimates, agreement will be rated poor (less than 0.50), moderate (between 0.50 and 0.75), good (between 0.75 and 0.90) or excellent (greater than 0.90). Mean differences and standard deviations will also be calculated and interpreted.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - People post-stroke or healthy test subjects - Language: Dutch, English or French - Age = 18 - Able to sit and stand unsupported for 30 s or more - Able to stand up from a chair without aid of another person - Able to signal pain, fear of discomfort - Able to give informed consent (based on the advice of a medical doctor) - Able to understand and perform the instructions and to answer questions Exclusion Criteria: - Concurrent orthopedic and/or musculoskeletal pathologies or disorders that may limit the range of motion (including limb amputations) - Concurrent neurological disorders (e.g. Parkinson's Disease, Multiple Sclerosis or Amyotrophic Lateral Sclerosis) - Persons with comorbidity that could hinder the study (e.g. unstable cardiovascular system disorders, lung disorders, severe osteoporosis) - People with difficulties of speech and/or memory providing that instruction cannot be followed or understood adequate

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Kinect validation
Participants will perform several movements while both the vicon and kinect are measuring.

Locations

Country Name City State
Belgium Brubotics Rehabilitation Research Center Brussel

Sponsors (1)

Lead Sponsor Collaborator
Vrije Universiteit Brussel

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary 3D kinematic measurements lower limb Kinematic data (i.e. movement amplitudes of the bilateral hip, knee and ankle joint in degrees) of the lower limbs during the movements will be recorded continuously with the use of the VICON Vero 1.3 system at 100 Hz. through study completion, an average of 1 year
Primary 3D kinematic measurements upper limb Kinematic data (i.e. movement amplitudes of the head, neck, spine, thorax and bilateral shoulder, elbow and wrist joint in degrees) of the lower limbs during the movements will be recorded continuously with the use of the VICON Vero 1.3 system at 100 Hz. through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1